Executive in Residence
Executives in Residence (XIRs) offer entrepreneurial expertise
Posted by Staff
Princeton University’s Office of Technology Licensing offers the services of Executives in Residence (XIRs), who are available to provide advice to faculty, students and staff who have discoveries in science and technology that could be used to create products and services to solve critical societal challenges and unmet needs. The creation of these societal benefits is a primary government objective for academic research. Each XIR brings to the position experience in leadership, business development, technology transfer and entrepreneurship.
The XIRs are located in the Office of Technology Licensing, 87 Prospect Avenue, 3rd Floor, and are available to meet with faculty, staff, postdoctoral researchers, graduate students and undergraduates who have questions about making their discoveries available for further development.
"Our new executives in residence bring real-world experience to the academic community here at Princeton," said John Ritter, director of the Office of Technology Licensing. "Both of our new executives have a great deal of experience working with our partners in the entrepreneurship community, and they are eager to share their knowledge and connections."
To arrange a meeting with an XIR, those in the University community should contact their Office of Technology Licensing associate or email Laurie Tzodikov at email@example.com.
Dr. Mahmoudian’s career spans 20 years in the biotechnology, pharmaceutical and chemical sectors. He joined Ferring Pharmaceuticals in 2012 as Vice President, Head of Innovative Medicines to build its future R&D pipeline in immunotherapy. Prior to that, he was at Merck leading the company's External Research and R&D Operations in vaccines, biologics and biosimilars (Merck BioVentures) on a global basis. At Dow he was the Global Head of Biotechnology overseeing all of research and strategic alliances in five sites (US, UK, France, China, Japan). Dr. Mahmoudian was recruited to Eastman earlier in his career as the Worldwide Head of Biotechnology responsible for R&D, partnering, managing growth and development of its BioProducts portfolio. He began his career at GlaxoSmithKline, where he held a variety of research, technology and management roles of increasing responsibility in drug discovery, preclinical development and BioPharm R&D.
Dr. Mahmoudian has extensive scientific and operations experience leading multi-national teams in R&D (discovery, preclinical, phase I-III), Chemistry, Manufacturing and Control (CMC), tech transfer, GMP biomanufacturing and the licensure of six "blockbuster" therapies.
Dr. Mahmoudian earned his Ph.D. in Biotechnology from Imperial College at the University of London. He serves on the advisory boards of several startups and universities and is a board member of the European Federation of Biotechnology. Dr. Mahmoudian is an elected Fellow of the Royal Society of Chemistry (FRSC) and has 60 publications and patents to his name.
Dr. Mahmoudian said he looks forward to his new role as XIR. "I am delighted to be able to serve as an Executive in Residence to guide Princeton University faculty who wish to externalize their discoveries and research inventions, bringing innovative medicines to patients with high unmet medical needs," he said.
Joseph Studholme is founder and CEO of Princeton Integrative Rx Analytics (PIRXA), a Princeton-based health care data research and development firm, and a founding member of Union Atlantic Ventures, where he is responsible for the overall operations and management of the firm, with a particular focus on deal origination and coaching management teams.
Prior to his current positions, Studholme was co-founder and COO of Restricted Stock Systems (RSS), a VC-backed financial software firm which he and his team took from a concept sketched on a napkin in August of 2000 to a leading supplier of financial software and services by October of 2007. Among other achievements, RSS was the New Jersey Tech Council Early Stage Company of the Year. Studholme got his start in the software business selling the first Macintosh computers on the floor of the Princeton University Store in 1984.
Studholme, who serves as president of the Graduate Board of one of the campus's historic eating clubs, Colonial Club, said he looks forward to his new role as XIR. "The University gave me my start in software and entrepreneurship, and I'm delighted to have the opportunity to go back to Old Nassau and help Princeton's faculty, staff, alumni and students create successful products and companies," he said.
Kef Kasdin has led Battelle Ventures' investments in clean technology since 2003 and started several companies based on U.S. Department of Energy technologies. She served as an independent consultant to several startups in communications, and in several management roles at 3Com Corporation, including head of a $1B division and leader of several key intrapreneurship initiatives. Kef received her Bachelor of Science in Engineering degree with highest honors from Princeton in what is now Operations Research and Financial Engineering (ORFE), with a certificate in science and policy from the Woodrow Wilson School. She earned her Master of Business Administration degree from Stanford’s Graduate School of Business. At Princeton she co-teaches the popular undergraduate course " Introduction to Entrepreneurship" with Ed Zschau of the Keller Center.
"I am really pleased that the university created this position. It is a good complement to the activities of the Office of Technology Licensing," said Kasdin. "I think it will be very valuable for the Princeton community to meet with someone who has been through the ups and downs of starting companies, and has experience advising new companies."